NO20045217L - Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander - Google Patents
Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstanderInfo
- Publication number
- NO20045217L NO20045217L NO20045217A NO20045217A NO20045217L NO 20045217 L NO20045217 L NO 20045217L NO 20045217 A NO20045217 A NO 20045217A NO 20045217 A NO20045217 A NO 20045217A NO 20045217 L NO20045217 L NO 20045217L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- formula
- thio
- hormone
- delivery
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US39182602P | 2002-06-25 | 2002-06-25 | |
PCT/US2003/019710 WO2004000225A2 (en) | 2002-06-25 | 2003-06-23 | Use of thio-oxindole derivatives in treatment of hormone-related conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20045217L true NO20045217L (no) | 2005-03-15 |
Family
ID=30000758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20045217A NO20045217L (no) | 2002-06-25 | 2004-11-29 | Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander |
Country Status (17)
Country | Link |
---|---|
US (3) | US7488734B2 (de) |
EP (1) | EP1531806A4 (de) |
JP (1) | JP2005535623A (de) |
CN (1) | CN1662234A (de) |
AR (1) | AR040339A1 (de) |
AU (1) | AU2003245637A1 (de) |
BR (1) | BR0312054A (de) |
CA (1) | CA2489813A1 (de) |
CR (1) | CR7610A (de) |
EC (1) | ECSP055574A (de) |
IL (1) | IL165395A0 (de) |
MX (1) | MXPA04012419A (de) |
NO (1) | NO20045217L (de) |
RU (1) | RU2005101635A (de) |
TW (1) | TW200407124A (de) |
WO (1) | WO2004000225A2 (de) |
ZA (1) | ZA200410409B (de) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6355648B1 (en) | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6407101B1 (en) * | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
US6509334B1 (en) * | 1999-05-04 | 2003-01-21 | American Home Products Corporation | Cyclocarbamate derivatives as progesterone receptor modulators |
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
UA73119C2 (en) * | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
MXPA04012419A (es) * | 2002-06-25 | 2005-04-19 | Wyeth Corp | Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con la hormona. |
SG151331A1 (en) * | 2004-04-07 | 2009-04-30 | Wyeth Corp | Crystalline polymorph of a bazedoxifene acetate |
JP2007532548A (ja) * | 2004-04-07 | 2007-11-15 | ワイス | バゼドキシフェンアセテートの結晶質多形体 |
BRPI0509213A (pt) * | 2004-04-08 | 2007-08-28 | Wyeth Corp | método para previnir, reduzir ou minimizar a formação de impurezas de tioamida durante a tionação de um composto de carbonila, produto, e, uso de um agente extrator |
ATE413398T1 (de) | 2004-04-08 | 2008-11-15 | Wyeth Corp | Thioamidderivate als progesteronrezeptormodulatoren |
US7556150B2 (en) * | 2004-06-07 | 2009-07-07 | Duramed Pharmaceuticals, Inc. | Dispenser for progestin used for acute and maintenance treatment of DUB |
GT200500185A (es) * | 2004-08-09 | 2006-04-10 | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
MY145694A (en) | 2005-04-11 | 2012-03-30 | Xenon Pharmaceuticals Inc | Spiroheterocyclic compounds and their uses as therapeutic agents |
MY144968A (en) | 2005-04-11 | 2011-11-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their uses as therapeutic agents |
WO2008060789A2 (en) | 2006-10-12 | 2008-05-22 | Xenon Pharmaceuticals Inc. | Use of spiro-oxindole compounds as therapeutic agents |
CA2710293A1 (en) * | 2007-12-20 | 2009-07-02 | Teva Women's Health, Inc. | Dosage regimens and pharmaceutical compositions and packages for emergency contraception |
SG10201703086VA (en) | 2008-10-17 | 2017-05-30 | Xenon Pharmaceuticals Inc | Spiro-oxindole compounds and their use as therapeutic agents |
EP2350091B1 (de) | 2008-10-17 | 2015-06-03 | Xenon Pharmaceuticals Inc. | Spiro-oxindol verbindungen und ihre verwendung als therapeutische wirkstoffe |
AR077252A1 (es) | 2009-06-29 | 2011-08-10 | Xenon Pharmaceuticals Inc | Enantiomeros de compuestos de espirooxindol y sus usos como agentes terapeuticos |
WO2011029782A1 (en) * | 2009-09-11 | 2011-03-17 | Bayer Schering Pharma Aktiengesellschaft | Substituted (heteroarylmethyl) thiohydantoins as anticancer drugs |
RU2544852C2 (ru) | 2009-10-14 | 2015-03-20 | Ксенон Фармасьютикалз Инк. | Способы синтеза спиро-оксиндольных соединений |
US9504671B2 (en) | 2010-02-26 | 2016-11-29 | Xenon Pharmaceuticals Inc. | Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
CN102939287B (zh) | 2010-06-10 | 2016-01-27 | 塞拉根制药公司 | 雌激素受体调节剂及其用途 |
US9193714B2 (en) | 2011-12-14 | 2015-11-24 | Seragon Pharmaceuticals, Inc. | Fluorinated estrogen receptor modulators and uses thereof |
TW201636017A (zh) | 2015-02-05 | 2016-10-16 | 梯瓦製藥國際有限責任公司 | 以螺吲哚酮化合物之局部調配物治療帶狀疱疹後遺神經痛之方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5461065A (en) * | 1993-10-15 | 1995-10-24 | Eli Lilly And Company | Methods for inhibiting endometriosis |
DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
US5446053A (en) * | 1993-12-21 | 1995-08-29 | Eli Lilly And Company | Methods of inhibiting dysfunctional uterine bleeding |
US5633011A (en) * | 1994-08-04 | 1997-05-27 | Alza Corporation | Progesterone replacement therapy |
US6653297B1 (en) * | 1997-07-03 | 2003-11-25 | Medical College Of Hampton Roads | Control of selective estrogen receptor modulators |
US6326392B1 (en) | 1997-11-06 | 2001-12-04 | American Home Products Corporation | Anti-estrogen plus progestin containing oral contraceptives |
WO2000024366A1 (de) | 1998-10-23 | 2000-05-04 | Aventis Pharma Deutschland Gmbh | Zubereitungen zur topischen applikation von antiandrogen wirksamen substanzen |
US6331562B1 (en) * | 1998-12-30 | 2001-12-18 | Signal Pharmaceuticals, Inc. | Compounds and methods for modulation of estrogen receptors |
IL143920A0 (en) | 1998-12-31 | 2002-04-21 | Sugen Inc | 3-heteroarylidenyl-2-indolinone derivatives and pharmaceutical compositions containing the same |
US6391907B1 (en) * | 1999-05-04 | 2002-05-21 | American Home Products Corporation | Indoline derivatives |
US6355648B1 (en) * | 1999-05-04 | 2002-03-12 | American Home Products Corporation | Thio-oxindole derivatives |
US6407101B1 (en) | 1999-05-04 | 2002-06-18 | American Home Products Corporation | Cyanopyrroles |
EP1206761B1 (de) | 1999-08-26 | 2007-10-03 | Automotive Systems Laboratory Inc. | Magnetischer sensor |
US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
US20010034340A1 (en) * | 2000-03-20 | 2001-10-25 | American Home Products Corporation | Hormone replacement therapy |
UA73119C2 (en) | 2000-04-19 | 2005-06-15 | American Home Products Corpoir | Derivatives of cyclic thiocarbamates, pharmaceutical composition including noted derivatives of cyclic thiocarbamates and active ingredients of medicines as modulators of progesterone receptors |
SK2052003A3 (en) * | 2000-08-23 | 2003-07-01 | Akzo Nobel Nv | 10-Aryl-11-Hbenzo [b]fluorene derivatives and analogs for medicinal use |
MXPA04012419A (es) | 2002-06-25 | 2005-04-19 | Wyeth Corp | Uso de derivados de tio-oxindol en el tratamiento de condiciones relacionadas con la hormona. |
KR20050013627A (ko) | 2002-06-25 | 2005-02-04 | 와이어쓰 | Pr 조절제로서의 사이클로티오카바메이트 유도체 및피부 질환을 치료하기 위한 이의 용도 |
TW200404548A (en) | 2002-06-25 | 2004-04-01 | Wyeth Corp | Pharmaceutical composition containing cyclothiocarbamate derivatives in treatment of hormone-related conditions |
WO2004000227A2 (en) | 2002-06-25 | 2003-12-31 | Wyeth | Use of thio-oxindole derivatives in treatment of skin disorders |
-
2003
- 2003-06-23 MX MXPA04012419A patent/MXPA04012419A/es unknown
- 2003-06-23 TW TW092116982A patent/TW200407124A/zh unknown
- 2003-06-23 CN CN038147807A patent/CN1662234A/zh active Pending
- 2003-06-23 CA CA002489813A patent/CA2489813A1/en not_active Abandoned
- 2003-06-23 BR BR0312054-6A patent/BR0312054A/pt not_active IP Right Cessation
- 2003-06-23 EP EP03739264A patent/EP1531806A4/de not_active Withdrawn
- 2003-06-23 AU AU2003245637A patent/AU2003245637A1/en not_active Abandoned
- 2003-06-23 IL IL16539503A patent/IL165395A0/xx unknown
- 2003-06-23 JP JP2004516125A patent/JP2005535623A/ja active Pending
- 2003-06-23 RU RU2005101635/15A patent/RU2005101635A/ru not_active Application Discontinuation
- 2003-06-23 US US10/601,438 patent/US7488734B2/en not_active Expired - Fee Related
- 2003-06-23 WO PCT/US2003/019710 patent/WO2004000225A2/en not_active Application Discontinuation
- 2003-06-24 AR ARP030102255A patent/AR040339A1/es unknown
-
2004
- 2004-11-29 NO NO20045217A patent/NO20045217L/no not_active Application Discontinuation
- 2004-12-08 CR CR7610A patent/CR7610A/es unknown
- 2004-12-23 ZA ZA200410409A patent/ZA200410409B/xx unknown
-
2005
- 2005-01-25 EC EC2005005574A patent/ECSP055574A/es unknown
-
2008
- 2008-12-17 US US12/336,588 patent/US8242098B2/en not_active Expired - Fee Related
-
2012
- 2012-05-08 US US13/466,375 patent/US20120220558A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US8242098B2 (en) | 2012-08-14 |
TW200407124A (en) | 2004-05-16 |
ECSP055574A (es) | 2005-04-18 |
EP1531806A2 (de) | 2005-05-25 |
BR0312054A (pt) | 2005-10-18 |
WO2004000225A3 (en) | 2004-06-10 |
EP1531806A4 (de) | 2005-09-21 |
AU2003245637A1 (en) | 2004-01-06 |
MXPA04012419A (es) | 2005-04-19 |
JP2005535623A (ja) | 2005-11-24 |
CR7610A (es) | 2006-05-29 |
US7488734B2 (en) | 2009-02-10 |
CN1662234A (zh) | 2005-08-31 |
US20090099223A1 (en) | 2009-04-16 |
WO2004000225A2 (en) | 2003-12-31 |
CA2489813A1 (en) | 2003-12-31 |
AR040339A1 (es) | 2005-03-30 |
IL165395A0 (en) | 2006-01-15 |
RU2005101635A (ru) | 2005-08-10 |
ZA200410409B (en) | 2006-05-31 |
US20120220558A1 (en) | 2012-08-30 |
US20040002535A1 (en) | 2004-01-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20045217L (no) | Anvendelse av tio-oxindolderivater for behandling av hormon relaterte tilstander | |
NO20045216L (no) | Anvendelse av cyklotiokarbamatderivater for behandling av hormon relaterte tilstander | |
NO20065499L (no) | Kontroll av gjennombruddsblodning i utvidede hormonelle svangerskapsforebyggende regimer | |
NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
NO20062679L (no) | Nye 17 β -hydroksysteroid-dehydrogenase-type 1-inhibitorer | |
NO20065678L (no) | 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer. | |
NO20070487L (no) | 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer. | |
NO20050832L (no) | Selektive estrogenreseptormodulatorer inneholdende en fenylsulonylgruppe | |
PE20070341A1 (es) | Derivados de pirrol como moduladores del receptor de progesterona | |
TW200621235A (en) | Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) | |
NO20073806L (no) | Substituerte pyridinyl og pyrimidinylderivater som modulatorer av metabolisme og behandling av lidelser relatert til dette | |
MY133378A (en) | Glucocorticoid receptor modulators | |
NO20083065L (no) | Nye N-sulfamoylpiperidinamider for profylakse eller behandling av overvekt og beslektede tilstander | |
NO20080441L (no) | Benzofuranonderivater som ikke-steroide progesteronreseptormodulatorer | |
ATE460412T1 (de) | Trisubstituierte thiophene als progesteronreceptor-modulatoren | |
NO20090457L (no) | Oksazolidon derivativer som PR modulatorer | |
NZ515353A (en) | Cyclothiocarbamate derivatives as progesterone receptor modulators | |
MX2009009514A (es) | Heterociclos sulfonilados utiles para la modulacion del receptor de progesterona. | |
NO20080440L (no) | Ikke-steroide progesteronreseptormodulatorer | |
ATE448215T1 (de) | Selektive östrogen-rezeptor-modulatoren | |
WO2008109055A8 (en) | Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor | |
CL2003001545A1 (es) | Compuestos derivados de 7,9-difluoro-5h-cromeno-[3,4-f]quinolina de formula i, moduladores selectivos del receptor de progesterona; composicion farmaceutica; y su uso en el tratamiento de sangrado uterino disfuncional, dismenorrea, endometriosis, lei | |
CY1109919T1 (el) | Παραγωγα της ινδολης που ειναι χρησιμα σα ρυθμιστες του υποδοχεα της προγεστερονης | |
WO2008077647A3 (de) | Alpha-aminoalkohole als nichtsteroidale progesteronrezeptor-modulatoren | |
FR2866565A1 (fr) | Utilisation d'un modulateur du il-8rb et/ou pac-1 pour le traitement de la rosacee |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |